Clinical trial
Schizophrenia Study In Adults
NCT00049946
Study timeline
Study start (unknown)2002-10-01Date precision: month
Registry last updated2017-08-16
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Schizophreniaunresolved
Interventions
talnetantDRUG
risperidoneDRUG
Sponsors & collaborators
GlaxoSmithKlinelead sponsor
Mapped research locations
San DiegoCalifornia, United States2NashvilleTennessee, United States1ClevelandOhio, United States1CincinnatiOhio, United States1TampaFlorida, United States1Washington D.C.District of Columbia, United States1Oklahoma CityOklahoma, United States1AustinTexas, United States1New HavenConnecticut, United States1SacramentoCalifornia, United States1OrangeCalifornia, United States1ScottsdaleArizona, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00049946 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.